Recent trials have demonstrated the positive effects of nasal insulin in individuals with schizophrenia, bipolar disorder, depression, smoking addiction, and improving olfaction in individuals with impairment in the sense of smell [112]. The gene discussed is INS; the disease is depressive disorder.